Sumitomo Pharma Co., Ltd. (TYO:4506)

Sumitomo Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 8, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	1,155,914	289,624	158,122	321,807	479,930	765,586
Market Cap Growth	387.35%	83.17%	-50.86%	-32.95%	-37.31%	37.35%
Enterprise Value	1,380,274	578,654	533,549	346,137	606,587	926,427
Last Close Price	2909.50	729.00	398.00	810.00	1180.81	1850.26
PE Ratio	7.47	12.26	-	-	8.51	13.62
Forward PE	12.70	19.16	-	-	11.10	19.40
PS Ratio	2.60	0.73	0.50	0.58	0.86	1.48
PB Ratio	4.35	1.71	1.01	0.79	0.71	1.18
P/TBV Ratio	-	-	-	-	34.15	37.03
P/FCF Ratio	50.22	36.19	-	92.74	20.09	5.91
P/OCF Ratio	38.57	17.55	-	26.96	15.36	5.65
PEG Ratio	0.52	1.27	1.27	1.27	1.27	1.27
EV/Sales Ratio	3.10	1.45	1.70	0.62	1.08	1.80
EV/EBITDA Ratio	9.94	15.00	-	-	6.17	12.04
EV/EBIT Ratio	11.85	44.43	-	-	10.12	17.06
EV/FCF Ratio	59.96	72.31	-	99.75	25.39	7.15
Debt / Equity Ratio	0.99	1.85	2.74	0.85	0.42	0.45
Debt / EBITDA Ratio	1.89	8.14	-	-	2.89	3.78
Debt / FCF Ratio	11.42	39.27	-	99.82	11.91	2.24
Asset Turnover	0.56	0.48	0.31	0.46	0.43	0.40
Inventory Turnover	1.81	1.46	1.21	1.85	1.64	1.61
Quick Ratio	0.83	0.43	0.25	0.65	1.27	1.19
Current Ratio	1.36	1.07	0.52	1.03	1.79	1.65
Return on Equity (ROE)	81.47%	14.52%	-111.89%	-17.90%	6.14%	5.75%
Return on Assets (ROA)	9.25%	0.99%	-21.74%	-6.46%	2.86%	2.65%
Return on Capital (ROIC)	14.15%	1.52%	-33.20%	-9.23%	3.95%	3.60%
Return on Capital Employed (ROCE)	20.20%	2.60%	-90.60%	-16.50%	5.80%	5.30%
Earnings Yield	13.39%	8.16%	-199.19%	-23.15%	11.75%	7.34%
FCF Yield	1.99%	2.76%	-159.79%	1.08%	4.98%	16.92%
Dividend Yield	-	-	-	2.59%	2.37%	1.51%
Payout Ratio	0.00%	0.01%	-	-	19.72%	19.78%
Total Shareholder Return	-	-	-	2.59%	2.37%	1.51%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.